Restex



Indications and Reactions:

Role Indications Reactions
Secondary
Restless Legs Syndrome 17.7%
Pain 17.2%
Hypertension 7.5%
Coronary Artery Disease 6.5%
Osteoporosis 4.3%
Dyslipidaemia 3.8%
Prophylaxis Against Gastrointestinal Ulcer 3.8%
Type 2 Diabetes Mellitus 3.8%
Asthma 3.2%
Chronic Myeloid Leukaemia 3.2%
Dizziness 3.2%
Hyperparathyroidism Secondary 3.2%
Hypothyroidism 3.2%
Nausea 3.2%
Prophylaxis 3.2%
Psychotic Disorder 3.2%
Renal Failure 3.2%
Vitamin Supplementation 3.2%
Contraception 2.2%
Hyperparathyroidism 1.1%
Transaminases Increased 28.0%
Ventricular Tachycardia 16.0%
Tachyarrhythmia 8.0%
Weight Decreased 8.0%
Dermatitis 4.0%
Drug Ineffective 4.0%
Dyspnoea Exertional 4.0%
Intentional Drug Misuse 4.0%
Pancytopenia 4.0%
Respiratory Distress 4.0%
Restlessness 4.0%
Somnolence 4.0%
Tremor 4.0%
Twin Pregnancy 4.0%
Concomitant
Product Used For Unknown Indication 40.8%
Restless Legs Syndrome 13.7%
Hypertension 11.1%
Pain 4.5%
Rheumatoid Arthritis 4.5%
Drug Use For Unknown Indication 3.0%
Coronary Artery Disease 2.6%
Hyperparathyroidism Secondary 2.6%
Renal Impairment 2.6%
Osteoporosis 1.9%
Multiple Sclerosis 1.6%
Anaemia 1.5%
Nausea 1.3%
Anticoagulant Therapy 1.2%
Atrial Fibrillation 1.2%
Depression 1.2%
Diarrhoea 1.2%
Polyuria 1.2%
Surgery 1.2%
Hyperlipidaemia 1.0%
Hydrocephalus 7.0%
Pulse Absent 7.0%
Arthropathy 5.6%
Coagulation Time Abnormal 5.6%
Gastrointestinal Haemorrhage 5.6%
Hypotension 5.6%
Rheumatoid Nodule 5.6%
Ventricular Fibrillation 5.6%
Weight Decreased 5.6%
Anaemia 4.2%
Arterial Occlusive Disease 4.2%
Faecaloma 4.2%
General Physical Health Deterioration 4.2%
Pneumonia 4.2%
Pneumothorax 4.2%
Pyelonephritis 4.2%
Skin Ulcer 4.2%
Tachyarrhythmia 4.2%
Thinking Abnormal 4.2%
Tongue Ulceration 4.2%
Interacting
Hypertension 14.5%
Pain 12.7%
Coronary Artery Disease 10.9%
Type 2 Diabetes Mellitus 9.1%
Dyslipidaemia 7.3%
Osteoporosis 7.3%
Prophylaxis Against Gastrointestinal Ulcer 7.3%
Restless Legs Syndrome 7.3%
Hyperparathyroidism Secondary 5.5%
Nausea 5.5%
Renal Failure 5.5%
Vitamin Supplementation 5.5%
Hyperparathyroidism 1.8%
Transaminases Increased 100.0%